April 2, 2021

Pfizer/BioNTech COVID-19 vaccine highly effective six months after second dose

Pfizer/BioNTech COVID-19 vaccine highly effective six months after second dose

The Pfizer/BioNTech COVID-19 vaccine is more than 91 percent effective six months after people get their second dose, according to new test data released by the companies.

The findings from more than 46,000 trial participants was released Thursday, CBS News reported. There were 927 confirmed symptomatic cases of COVID-19 overall, with 850 cases in the and 77 cases among those who received the vaccine.

The companies also announced that the vaccine is safe and effective in children as young as 12 years, and they plan to seek emergency use authorization in the United States and Europe for the vaccine to be given starting at age 12 years, CBS News reported.

That means that children 12 years and older could start receiving the vaccine before going back to school in the fall.

More information: CBS News Article

Copyright © 2021 HealthDay. All rights reserved.

Citation: Pfizer/BioNTech COVID-19 vaccine highly effective six months after second dose (2021, April 2) retrieved 25 April 2024 from https://medicalxpress.com/news/2021-04-pfizerbiontech-covid-vaccine-highly-effective.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak
5 shares

Feedback to editors
Genetic variations may predispose people to Parkinson's disease following long-term pesticide exposure, study finds

1 hour ago
Link between depression and cardiovascular disease explained: They partly develop from same gene module

6 hours ago
Study highlights increased risk of second cancers among breast cancer survivors

11 hours ago
Opioids during pregnancy not linked to substantially increased risk of psychiatric disorders in children

12 hours ago
Research identifies pitfalls and opportunities for generative AI in patient messaging systems

12 hours ago
A closed-loop drug-delivery system could improve chemotherapy

13 hours ago
It's easier now to treat opioid addiction with medication—but use has changed little, study finds

13 hours ago
Solving the riddle of the sphingolipids in coronary artery disease

13 hours ago
New AI technology estimates brain age using low-cost EEG device

14 hours ago
Alteration of brain network condition could predict painful vaso-occlusive crisis in patients with sickle cell disease

15 hours ago
Load comments (0)